|
Volumn 38, Issue 6, 2000, Pages 701-705
|
Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract
|
Author keywords
Bacillus Calmette Guerin; Carcinoma in situ; Upper urinary tract
|
Indexed keywords
BCG VACCINE;
IMMUNOLOGICAL ADJUVANT;
ADULT;
AGED;
ARTICLE;
BLADDER BIOPSY;
BLADDER IRRITATION;
CANCER MORTALITY;
CANCER RECURRENCE;
CARCINOMA IN SITU;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG INSTILLATION;
DRUG SAFETY;
FEVER;
HUMAN;
LYMPHOMA;
MALE;
NEPHROURETERECTOMY;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
RADIODIAGNOSIS;
RECTUM CANCER;
TRANSITIONAL CELL CARCINOMA;
URINARY TRACT CARCINOMA;
URINE CYTOLOGY;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FOLLOW UP;
INTRAVESICAL DRUG ADMINISTRATION;
KIDNEY TUMOR;
PERFUSION;
STENT;
TIME;
URETER TUMOR;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRAVESICAL;
AGED;
BCG VACCINE;
CARCINOMA IN SITU;
CARCINOMA, TRANSITIONAL CELL;
DISEASE-FREE SURVIVAL;
FOLLOW-UP STUDIES;
HUMANS;
INSTILLATION, DRUG;
KIDNEY NEOPLASMS;
MALE;
PERFUSION;
STENTS;
TIME FACTORS;
URETERAL NEOPLASMS;
|
EID: 0033668141
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000020365 Document Type: Article |
Times cited : (70)
|
References (21)
|